647-28804-16425
3 vaccinations
14 coded responses
36 check-ins
14 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 802 / CO
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Issues started about 7h post injection, peaked at ~14h post injection and are subsiding rapidly.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Hunger — Feeling: GoodFree text: Hungry to the point of famishedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-04-16
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-04-24
Survey response — days 1–6 daily, dose 2MedDRA: Hunger — Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: HungerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Hunger — Feeling: Good · Site: Pain, SwellingFree text: Ravenous hungerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-04-27
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
-
2021-10-26
Survey response — 6 months, dose 2MedDRA: Asthenia, Autonomic nervous system imbalance, Brain fog, Breakthrough COVID-19, Escherichia infection, Hypoxia, Pneumonia, Pneumothorax, Tachycardia, Thrombosis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Breakthrough Covid, first symptoms ~8/25. Got ALL common symptoms plus blood clots, pneumonia, collapsed lungs, severe hypoxia, tacycardia, disautonamia, brain fog, EXTREME loss of energy, and opportunistic e. coli infection.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2021-10-28
-
2021-11-19
Dose 3 — ModernaCo-administered: Flu
-
2021-11-19
Survey response — day 0, dose 3MedDRA: Breakthrough COVID-19, Tachycardia — Feeling: Fair · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tachycardia, likely from breakthrough covid infectionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body achesAdult check-in
-
2021-11-21
Survey response — days 1–6 daily, dose 3MedDRA: Insomnia — Feeling: Good · Site: Pain, Redness, Swelling · Nausea, VomitingFree text: InsomniaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-11-23
Survey response — days 1–6 daily, dose 3MedDRA: Breakthrough COVID-19, Hypoxia, Oxygen saturation decreased — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Hypoxia - O2 sats mid 80s; this has been a recurring problem since breakthrough covid and may not be related to the vaccineMedDRA releases: 2024-11 · check-in free text available
-
2021-11-24
Survey response — days 1–6 daily, dose 3MedDRA: Hypoxia — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: HypoxiaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Survey response — days 1–6 daily, dose 3MedDRA: Hypoxia — Feeling: Fair · Fatigue or tiredness · Be unable to work or attend schoolFree text: HypoxiaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — day 7, dose 3MedDRA: Hypoxia, Tachycardia — Feeling: Good · Fatigue or tirednessFree text: Tachycardia easing. Still mildly hypoxic.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-05
- 2021-12-14
-
2021-12-19
Survey response — day 28, dose 3MedDRA: Breakthrough COVID-19, Urinary tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: UTI from earlier covid breakthrough broke through Shannon.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-26
- 2021-12-31
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Depression, Hypoxia, Tachycardia, Urinary tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tachycardia, hypoxia, uti, depressionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-25
Survey response — 6 months, dose 3MedDRA: COVID-19, Post-acute COVID-19 syndrome — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Got covid again about 3 weeks ago. Still feeling long covid from August 2021 infection.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Moderna | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Issues started about 7h post injection, peaked at ~14h post injection and are subsiding rapidly.
Systemic reaction (other): Hungry to the point of famished
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Hunger
Systemic reaction (other): Ravenous hunger
Release 10 — 6 months, dose 2
Symptoms: Breakthrough Covid, first symptoms ~8/25. Got ALL common symptoms plus blood clots, pneumonia, collapsed lungs, severe hypoxia, tacycardia, disautonamia, brain fog, EXTREME loss of energy, and opportunistic e. coli infection.
Release 10 — day 0, dose 3
Systemic reaction (other): Tachycardia, likely from breakthrough covid infection
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Insomnia
Systemic reaction (other): Hypoxia - O2 sats mid 80s; this has been a recurring problem since breakthrough covid and may not be related to the vaccine
Systemic reaction (other): Hypoxia
Systemic reaction (other): Hypoxia
Release 10 — day 7, dose 3
Systemic reaction (other): Tachycardia easing. Still mildly hypoxic.
Release 10 — day 28, dose 3
Symptoms: UTI from earlier covid breakthrough broke through Shannon.
Release 11 — 3 months, dose 3
Symptoms: Tachycardia, hypoxia, uti, depression
Release 11 — 6 months, dose 3
Symptoms: Got covid again about 3 weeks ago. Still feeling long covid from August 2021 infection.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Autonomic nervous system imbalance | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Breakthrough COVID-19 | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Escherichia infection | · | · | ✓ |
| SD | Hypoxia | · | · | ✓ |
| SD | Pneumonia | · | · | ✓ |
| SD | Pneumothorax | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Breakthrough COVID-19 | · | · | ✓ |
| SRO | Hunger | ✓ | ✓ | ✓ |
| SRO | Hypoxia | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Oxygen saturation decreased | · | · | ✓ |
| SRO | Tachycardia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release